Patents by Inventor Luisa Mestroni

Luisa Mestroni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CARBON NANOTUBE-FUNCTIONALIZED REVERSE THERMAL GEL AND METHODS OF FORMING AND USING SAME
    Publication number: 20230220148
    Abstract: Polymers suitable for forming carbon nanotube-functionalized reverse thermal gel compositions, compositions including the polymers, and methods of forming and using the polymers and compositions are disclosed. The compositions have reverse thermal gelling properties and transform from a liquid/solution to a gel—e.g., near or below body temperature. The polymers and compositions can be injected into or proximate an area in need of treatment.
    Type: Application
    Filed: March 21, 2023
    Publication date: July 13, 2023
    Inventors: Daewon Park, Brisa Pena Castellanos, Susanna Bosi, Luisa Mestroni, Maurizio Prato
  • Carbon nanotube-functionalized reverse thermal gel and methods of forming and using same
    Patent number: 11608407
    Abstract: Polymers suitable for forming carbon nanotube-functionalized reverse thermal gel compositions, compositions including the polymers, and methods of forming and using the polymers and compositions are disclosed. The compositions have reverse thermal gelling properties and transform from a liquid/solution to a gel—e.g., near or below body temperature. The polymers and compositions can be injected into or proximate an area in need of treatment.
    Type: Grant
    Filed: September 19, 2018
    Date of Patent: March 21, 2023
    Assignee: The Regents of the University of Colorado, A Body Corporate
    Inventors: Daewon Park, Brisa Pena Castellanos, Susanna Bosi, Luisa Mestroni, Maurizio Prato
  • CARBON NANOTUBE-FUNCTIONALIZED REVERSE THERMAL GEL AND METHODS OF FORMING AND USING SAME
    Publication number: 20200216601
    Abstract: Polymers suitable for forming carbon nanotube-functionalized reverse thermal gel compositions, compositions including the polymers, and methods of forming and using the polymers and compositions are disclosed. The compositions have reverse thermal gelling properties and transform from a liquid/solution to a gel—e.g., near or below body temperature. The polymers and compositions can be injected into or proximate an area in need of treatment.
    Type: Application
    Filed: September 19, 2018
    Publication date: July 9, 2020
    Inventors: Daewon Park, Brisa Pena Castellanos, Susanna Bosi, Luisa Mestroni, Maurizio Prato
  • Endothelin single nucleotide polymorphisms and methods of predicting ?-adrenergic receptor targeting agent efficacy
    Patent number: 10258606
    Abstract: The present invention concerns the use of methods for evaluating ?-adrenergic receptor targeting agent treatment for a patient, particularly one with a heart condition. In general, the disclosed methods entail determining the presence or absence of one or more polymorphisms in an endothelin gene system member. Based on the results of this determination, a ?-adrenergic receptor targeting agent may be prescribed, administered or a treatment regimen altered, including the administration of a ?-blocker. Accordingly, methods of treatment are also described.
    Type: Grant
    Filed: June 22, 2015
    Date of Patent: April 16, 2019
    Assignee: The Regents of the University of Colorado, A Body Corporate
    Inventors: Matthew R. G. Taylor, Luisa Mestroni
  • CARBON-NANOTUBE MODULATION OF MYOCYTE CELLS
    Publication number: 20170145384
    Abstract: Embodiments include compositions of carbon nanotubes complexed with myocyte cells. Embodiments also include methods for making compositions of carbon nanotubes, and methods for modulating the electrophysical, proliferative, and viability potential of myocytes.
    Type: Application
    Filed: December 15, 2016
    Publication date: May 25, 2017
    Inventors: Luisa Mestroni, Laura Ballerini, Carlin Long, John Caldwell, Maurizio Prato, Valentina Martinelli, Giada Cellot, Francesca Maria Toma, Lorena Zentilin
  • Endothelin Single Nucleotide Polymorphisms and Methods of Predicting B-Adrenergic Receptor Targeting Agent Efficacy
    Publication number: 20150366843
    Abstract: The present invention concerns the use of methods for evaluating ?-adrenergic receptor targeting agent treatment for a patient, particularly one with a heart condition. In general, the disclosed methods entail determining the presence or absence of one or more polymorphisms in an endothelin gene system member. Based on the results of this determination, a ?-adrenergic receptor targeting agent may be prescribed, administered or a treatment regimen altered, including the administration of a ?-blocker. Accordingly, methods of treatment are also described.
    Type: Application
    Filed: June 22, 2015
    Publication date: December 24, 2015
    Inventors: Matthew R.G. Taylor, Luisa Mestroni
  • Endothelin single nucleotide polymorphisms and methods of predicting ?-adrenergic receptor targeting agent efficacy
    Patent number: 9062347
    Abstract: The present invention concerns the use of methods for evaluating ?-adrenergic receptor targeting agent treatment for a patient, particularly one with a heart condition. In general, the disclosed methods entail determining the presence or absence of one or more polymorphisms in an endothelin gene system member. Based on the results of this determination, a ?-adrenergic receptor targeting agent may be prescribed, administered or a treatment regimen altered, including the administration of a ?-blocker. Accordingly, methods of treatment are also described.
    Type: Grant
    Filed: July 28, 2008
    Date of Patent: June 23, 2015
    Assignee: The Regents of the University of Colorado, a body corporate
    Inventors: Matthew R. G. Taylor, Luisa Mestroni
  • CARBON-NANOTUBE MODULATION OF MYOCYTE CELLS
    Publication number: 20140087461
    Abstract: Embodiments include compositions of carbon nanotubes complexed with myocyte cells. Embodiments also include methods for making compositions of carbon nanotubes, and methods for modulating the electrophysical, proliferative, and viability potential of myocytes.
    Type: Application
    Filed: March 13, 2012
    Publication date: March 27, 2014
    Applicants: UNIVERSITY OF TRIESTE, INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY, THE REGENTS OFTHE UNIVERSITY OF COLORADO, A BODY CORPORATE
    Inventors: Luisa Mestroni, Laura Ballerini, Carlin Long, John Caldwell, Maurizio Prato, Valentina Martinelli, Giada Cellot, Francesca Maria Toma, Lorena Zentilin
  • Endothelin Single Nucleotide Polymorphisms and Methods of Predicting B-Adrenergic Receptor Targeting Agent Efficacy
    Publication number: 20100298399
    Abstract: The present invention concerns the use of methods for evaluating ?-adrenergic receptor targeting agent treatment for a patient, particularly one with a heart condition. In general, the disclosed methods entail determining the presence or absence of one or more polymorphisms in an endothelin gene system member. Based on the results of this determination, a ?-adrenergic receptor targeting agent may be prescribed, administered or a treatment regimen altered, including the administration of a ?-blocker. Accordingly, methods of treatment are also described.
    Type: Application
    Filed: July 28, 2008
    Publication date: November 25, 2010
    Inventors: Matthew R. G. Taylor, Luisa Mestroni